Nucleic Acid Nanotechnology Originated ProtoCell - NANOPC
Nucleic Acid Nanotechnology Originated ProtoCell - NANOPC
批准号:
EP/X023303/1
负责人:
Wooli Bae
金额:
$44.58万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cells, the basic units of life, are dynamic systems that sense the environment and adapt to it through a variety of responses. Understanding and engineering living cells, although highly rewarding, is greatly challenging, due to the complexity of biochemical networks that underlie a cell's most sophisticated functions. A simpler synthetic alternative to real cells - protocells - can therefore be built to design systems with cell-like traits. Protocells promise to facilitate our understanding of the principles of biology, and could, have important medical and engineering implications. Despite recent progress, current protocell systems fail to mimic core operating principles of cells to continuously operate, interact with the external environment, and process information to make decisions. Here, we will develop a Nucleic Acid Nanotechnology Originated ProtoCell (NANOPC) system using rationally designed DNA and RNA components. State-of-the-art DNA/RNA nanotechnology will be used to build nanostructures and reaction circuits that mimic proteins and genetic networks of a cell with unprecedented precision. Reaction circuits made of DNA and RNA are fully programmable and can be easily combined to each other, which will allow us in the long run, to build complex multifunctional protocells on demand. In addition, the NANOPC will continuously operate these reaction circuits at dynamic equilibrium by using my recent achievement to produce RNA components in situ. The reaction circuits will be used to control the uptake of nutrients from the external environment, implementing sensing-mediated controls for example, in feedback loops. By programming NA nanostructures and reaction circuits, the NANOPC will be able to implement emergent cellular behaviours such as the ability to maintain its internal stability (homeostasis) and processing information. Therefore, the NANOPC will be a novel platform to study basic principles of biology. The versatility of DNA/RNA nanotechnology will ultimately enable NANOPC to generate biomedical and engineering applications. For example, the NANOPC could be a high throughput platform for prototyping biochemical networks or a smart drug delivery system to sense tumour microenvironment, process multiple information to release drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Japan_IPAP: High-Throughput Prototyping of Heterogeneity in genetic networks using Artificial Cells with femtolitre volume (HT-PHAC)
-
批准号:BB/X01262X/1
-
项目类别:Research Grant
-
资助金额:$19.35万
-
财政年份:2023
-
负责人:Wooli Bae
-
依托单位:
国内基金
海外基金
登录
查看更多内容
棕榈酸Palmitic acid通过靶向JAK-STAT通路促进致病性Th17细胞分化在儿童性系统性红斑狼疮中的作用及机制研究
-
批准号:2026JJ81716
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐金玲
-
依托单位:
基于F/IGF1R/PKC ζ 通路研究夏枯草中
Mesonolic acid B抑制RSV感染性肺炎的
作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:唐维
-
依托单位:
Quinic acid通过抑制肠道菌群代谢产物脱氧胆酸调节巨噬细胞M1向M2极化改善动脉粥样硬化的机制研究
-
批准号:2025JJ80556
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吴鹏翠
-
依托单位:
巨噬细胞来源代谢物suberic acid抑制蜕膜早衰防治早产的作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:梅又文
-
依托单位:
色氨酸代谢产物Kynurenic Acid在脓毒症肠损伤中的诊断价值及其机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:5.0万元
-
批准年份:2024
-
负责人:陈慧
-
依托单位:
石榴皮活性成分Ellagic acid调控脂肪酸代谢重编程抑制NASH相关肝癌发生的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
具有抗耐药甲氧西林金黄色葡萄球菌活性天然产物quiannulatic acid的分子作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2022
-
负责人:韩晓乐
-
依托单位:
丹参红花药对活性组分 Salvianolic acid B-Hydrosafflow yellow A 调控Piezo1-YAP/TAZ-JNK 调节动脉粥样硬化炎症反应机制的研究
-
批准号:LQ22H290004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张春晓
-
依托单位:
DPA(docosapentaenoic acid, 22:5n-3)对溃疡性结肠炎小鼠肠道菌群影响及特异性菌群筛选的研究
-
批准号:LQ22C200008
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:郑振霄
-
依托单位:
木霉菌抗真菌物质Harzianic Acid的合成机制及其应用研究
-
批准号:32072674
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张建
-
依托单位: